Places are limited, sign up now!
Join #TeamActionBladderCancerUK whether you’re a seasoned runner or taking on your first half marathon, every step you take helps make a difference
Sign up for one of our charity places today: events@actionbladdercanceruk.org
#LLHM2026 #RunForACause #BladderCancer
Join #TeamActionBladderCancerUK whether you’re a seasoned runner or taking on your first half marathon, every step you take helps make a difference
Sign up for one of our charity places today: events@actionbladdercanceruk.org
#LLHM2026 #RunForACause #BladderCancer
January 12, 2026 at 8:37 AM
Places are limited, sign up now!
Join #TeamActionBladderCancerUK whether you’re a seasoned runner or taking on your first half marathon, every step you take helps make a difference
Sign up for one of our charity places today: events@actionbladdercanceruk.org
#LLHM2026 #RunForACause #BladderCancer
Join #TeamActionBladderCancerUK whether you’re a seasoned runner or taking on your first half marathon, every step you take helps make a difference
Sign up for one of our charity places today: events@actionbladdercanceruk.org
#LLHM2026 #RunForACause #BladderCancer
Do you have a project that could improve bladder cancer outcomes or support patients?
Apply for funding of up to £10,000. Applications are open until 30 March 2026.
#bladdercancer #urologynurse
Apply for funding of up to £10,000. Applications are open until 30 March 2026.
#bladdercancer #urologynurse
January 10, 2026 at 6:00 PM
Do you have a project that could improve bladder cancer outcomes or support patients?
Apply for funding of up to £10,000. Applications are open until 30 March 2026.
#bladdercancer #urologynurse
Apply for funding of up to £10,000. Applications are open until 30 March 2026.
#bladdercancer #urologynurse
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQGMGG !
#Oncology #SocialListening #LucidQuest
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQGMGG !
#Oncology #SocialListening #LucidQuest
ASCO_GU_ 2025_Social_Media_Report.pdf
dlvr.it
January 10, 2026 at 10:19 AM
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQGMGG !
#Oncology #SocialListening #LucidQuest
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQGMGG !
#Oncology #SocialListening #LucidQuest
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive #BladderCancer (NMIBC). www.annalsofoncology.org/article/S092...
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-m...
Standard treatment of high-risk non-muscle-invasive bladder cancer (NMIBC) after transurethral
resection of bladder tumor is intravesical instillation with Bacillus Calmette–Guérin
(BCG) (induction an...
www.annalsofoncology.org
January 8, 2026 at 2:31 PM
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive #BladderCancer (NMIBC). www.annalsofoncology.org/article/S092...
Around 20,000 people are diagnosed with #BladderCancer in the UK each year.
The TRAIN trial will see if #radiotherapy can improve outcomes for patients with early-stage #cancer which has not spread into the deeper layers of the bladder.
📽️ Watch our video to find out more youtu.be/AibJxJ53QZ0
The TRAIN trial will see if #radiotherapy can improve outcomes for patients with early-stage #cancer which has not spread into the deeper layers of the bladder.
📽️ Watch our video to find out more youtu.be/AibJxJ53QZ0
The TRAIN bladder cancer trial
YouTube video by Southampton CTU
youtu.be
January 8, 2026 at 8:54 AM
Around 20,000 people are diagnosed with #BladderCancer in the UK each year.
The TRAIN trial will see if #radiotherapy can improve outcomes for patients with early-stage #cancer which has not spread into the deeper layers of the bladder.
📽️ Watch our video to find out more youtu.be/AibJxJ53QZ0
The TRAIN trial will see if #radiotherapy can improve outcomes for patients with early-stage #cancer which has not spread into the deeper layers of the bladder.
📽️ Watch our video to find out more youtu.be/AibJxJ53QZ0
£75 funds attendance at an #ABCUK learning day for one specialist #urologynurse
We cover all nurse expenses to make sure everyone can participate.
Your support makes this possible.
To find out more visit: actionbladdercanceruk.org/nurse-educat... and click on the ‘donate’ button.
#bladdercancer
We cover all nurse expenses to make sure everyone can participate.
Your support makes this possible.
To find out more visit: actionbladdercanceruk.org/nurse-educat... and click on the ‘donate’ button.
#bladdercancer
January 8, 2026 at 8:37 AM
£75 funds attendance at an #ABCUK learning day for one specialist #urologynurse
We cover all nurse expenses to make sure everyone can participate.
Your support makes this possible.
To find out more visit: actionbladdercanceruk.org/nurse-educat... and click on the ‘donate’ button.
#bladdercancer
We cover all nurse expenses to make sure everyone can participate.
Your support makes this possible.
To find out more visit: actionbladdercanceruk.org/nurse-educat... and click on the ‘donate’ button.
#bladdercancer
#Menin is upregulated in #BladderCancer, driving poor prognosis via TFAP2C/β‑catenin signaling; MEN1 silencing suppressed proliferation, while BAY‑155 inhibited #tumor growth, underscoring menin as a promising therapeutic target for #BLCA.
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
January 7, 2026 at 5:23 PM
#Menin is upregulated in #BladderCancer, driving poor prognosis via TFAP2C/β‑catenin signaling; MEN1 silencing suppressed proliferation, while BAY‑155 inhibited #tumor growth, underscoring menin as a promising therapeutic target for #BLCA.
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
Grants have been awarded for studying haematuria ward admission, sexual function post cystectomy, the effects of social deprivation on disease characteristics and survival outcomes & much more.
Read about previous projects: actionbladdercanceruk.org/abc-uk-grants/
#CancerFunding #BladderCancer
Read about previous projects: actionbladdercanceruk.org/abc-uk-grants/
#CancerFunding #BladderCancer
January 6, 2026 at 8:37 AM
Grants have been awarded for studying haematuria ward admission, sexual function post cystectomy, the effects of social deprivation on disease characteristics and survival outcomes & much more.
Read about previous projects: actionbladdercanceruk.org/abc-uk-grants/
#CancerFunding #BladderCancer
Read about previous projects: actionbladdercanceruk.org/abc-uk-grants/
#CancerFunding #BladderCancer
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ7Nkk !
#Oncology #SocialListening #LucidQuest
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ7Nkk !
#Oncology #SocialListening #LucidQuest
ASCO_GU_ 2025_Social_Media_Report.pdf
drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view
dlvr.it
January 3, 2026 at 8:58 AM
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ7Nkk !
#Oncology #SocialListening #LucidQuest
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ7Nkk !
#Oncology #SocialListening #LucidQuest
The role of HER2 in advanced bladder cancer is rapidly expanding.
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
January 2, 2026 at 8:51 PM
The role of HER2 in advanced bladder cancer is rapidly expanding.
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
Have you had treatment for muscle invasive #BladderCancer? Are you expecting surgery next?
If your scans show no cancer, you may be able to join #ClinicalTrial S2427 (also called BRIGHT).
Visit SWOG.org/S2427 to learn more. Or call 1-800-4-CANCER. #BladderPreservation
If your scans show no cancer, you may be able to join #ClinicalTrial S2427 (also called BRIGHT).
Visit SWOG.org/S2427 to learn more. Or call 1-800-4-CANCER. #BladderPreservation
January 1, 2026 at 6:10 PM
Have you had treatment for muscle invasive #BladderCancer? Are you expecting surgery next?
If your scans show no cancer, you may be able to join #ClinicalTrial S2427 (also called BRIGHT).
Visit SWOG.org/S2427 to learn more. Or call 1-800-4-CANCER. #BladderPreservation
If your scans show no cancer, you may be able to join #ClinicalTrial S2427 (also called BRIGHT).
Visit SWOG.org/S2427 to learn more. Or call 1-800-4-CANCER. #BladderPreservation
As the year comes to a close, we want to send a huge THANK YOU to all our incredible fundraisers. Your dedication, creativity, and hard work have made such a difference to those affected by bladder cancer.
#ThankYou #BladderCancerAwareness #Fundraisers #ABCUK #BladderCancer
#ThankYou #BladderCancerAwareness #Fundraisers #ABCUK #BladderCancer
December 31, 2025 at 6:00 PM
As the year comes to a close, we want to send a huge THANK YOU to all our incredible fundraisers. Your dedication, creativity, and hard work have made such a difference to those affected by bladder cancer.
#ThankYou #BladderCancerAwareness #Fundraisers #ABCUK #BladderCancer
#ThankYou #BladderCancerAwareness #Fundraisers #ABCUK #BladderCancer
Dr. Matt Galsky of Icahn School of Medicine at Mt Sinai of leads Alliance for Clinical Trials in Oncology A032103/MODERN testing the role of DNA released from tumor cells into the blood in guiding the use of #immunotherapy in #bladdercancer treatment: https://bit.ly/Alliance-A032103
December 30, 2025 at 2:30 PM
Dr. Matt Galsky of Icahn School of Medicine at Mt Sinai of leads Alliance for Clinical Trials in Oncology A032103/MODERN testing the role of DNA released from tumor cells into the blood in guiding the use of #immunotherapy in #bladdercancer treatment: https://bit.ly/Alliance-A032103
Cretostimogene grenadenorepvec prolongs high-grade event-free survival in patients with high-risk, papillary-only #NMIBC that fails to respond to BCG. Mark Tyson, MD of @mayoclinic.org presented at #SUO25, from @renalurologynews.bsky.social.
https://bit.ly/4paeufm
#bladdercancer
https://bit.ly/4paeufm
#bladdercancer
Cretostimogene Yields Durable Event-Free Survival in Papillary, BCG-Unresponsive NMIBC - Oncology Nurse Advisor
The phase 3, open-label, single arm BOND-003 trial also evaluated cretostimogene in cohort P with papillary-only high-grade NMIBC who failed prior BCG therapy.
bit.ly
December 28, 2025 at 6:24 PM
Cretostimogene grenadenorepvec prolongs high-grade event-free survival in patients with high-risk, papillary-only #NMIBC that fails to respond to BCG. Mark Tyson, MD of @mayoclinic.org presented at #SUO25, from @renalurologynews.bsky.social.
https://bit.ly/4paeufm
#bladdercancer
https://bit.ly/4paeufm
#bladdercancer
Application of computed diffusion-weighted imaging in vesical imaging reporting and data system assessment for bladder cancer.
Cai, Wenji et al.
Paper
Details
#DiffusionWeightedImaging #BladderCancer #VUDSAssessment
Cai, Wenji et al.
Paper
Details
#DiffusionWeightedImaging #BladderCancer #VUDSAssessment
December 28, 2025 at 9:01 AM
Application of computed diffusion-weighted imaging in vesical imaging reporting and data system assessment for bladder cancer.
Cai, Wenji et al.
Paper
Details
#DiffusionWeightedImaging #BladderCancer #VUDSAssessment
Cai, Wenji et al.
Paper
Details
#DiffusionWeightedImaging #BladderCancer #VUDSAssessment
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ1gfb !
#Oncology #SocialListening #LucidQuest
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ1gfb !
#Oncology #SocialListening #LucidQuest
ASCO_GU_ 2025_Social_Media_Report.pdf
2025 Genitourinary Cancers Symposium
Accelerate your success ASCO GU 2025
• Social Media Insights at Medical / Scientific Congresses 3
• Our methodology 4
• Key takeaways 5
• Conference-related SM activity over time 6
• Top hashtags used 7
• Top discussion themes 8
• Top Leading Voices 9
• Sentiment Analysis 10
• Most frequently used words and phrases 11
• LucidQuest’s SM Insights’ capabilities 12
• Get in touch 13
1. Insights on which
and which to avoid
hashtags that can
to your preferred
resonates with
with existing or
The LucidQuest Social Media Insights team monitored approximately 16.1K posts before,
during, and after ASCO GU 2025 to identify key hashtags, top discussion themes, top
Our team analyzed the absolute frequency of relevant hashtags found in
2.5K posts, and compiled a list of the top most frequent ones.
The text of top 500 posts was analyzed to identify the top discussion
themes and most frequent phrases and words used.
We leveraged our LQ algorithm, which takes into account both user
activity and popularity, to identify the top Leading Voices at the event.
Finally, we analyzed the text of top 500 posts to assess overall
sentiment and audience perceptions of the conference
We filtered posts in the top 25% of views to identify the top 500 ones.
dlvr.it
December 26, 2025 at 7:05 PM
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ1gfb !
#Oncology #SocialListening #LucidQuest
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQ1gfb !
#Oncology #SocialListening #LucidQuest
Researchers summarize how iron-dependent #LipidPeroxidation drives #ferroptosis, outline the metabolic and signaling pathways regulating ferroptosis in #BladderCancer, and highlight emerging ferroptosis inducers and combination strategies.
#OpenAccess: doi.org/10.1007/s115...
#OpenAccess: doi.org/10.1007/s115...
December 26, 2025 at 12:30 PM
Researchers summarize how iron-dependent #LipidPeroxidation drives #ferroptosis, outline the metabolic and signaling pathways regulating ferroptosis in #BladderCancer, and highlight emerging ferroptosis inducers and combination strategies.
#OpenAccess: doi.org/10.1007/s115...
#OpenAccess: doi.org/10.1007/s115...
Merry Christmas from Action Bladder Cancer UK! 🎄
Wishing our amazing community a bright, joyful day. Thank you for your strength and support this year, here’s to hope, happiness and health!
#bladdercancer #bladdercancerawareness #merrychristmas
Wishing our amazing community a bright, joyful day. Thank you for your strength and support this year, here’s to hope, happiness and health!
#bladdercancer #bladdercancerawareness #merrychristmas
December 25, 2025 at 8:37 AM
Merry Christmas from Action Bladder Cancer UK! 🎄
Wishing our amazing community a bright, joyful day. Thank you for your strength and support this year, here’s to hope, happiness and health!
#bladdercancer #bladdercancerawareness #merrychristmas
Wishing our amazing community a bright, joyful day. Thank you for your strength and support this year, here’s to hope, happiness and health!
#bladdercancer #bladdercancerawareness #merrychristmas
Bladder removal surgery can have a big impact on quality of life. Study S2427 (also called BRIGHT) is testing a possible #BladderSparing approach for people with muscle invasive #BladderCancer. To learn more, visit SWOG.org/S2427 or call 1-800-4-CANCER. #MIBC
December 24, 2025 at 4:20 PM
Bladder removal surgery can have a big impact on quality of life. Study S2427 (also called BRIGHT) is testing a possible #BladderSparing approach for people with muscle invasive #BladderCancer. To learn more, visit SWOG.org/S2427 or call 1-800-4-CANCER. #MIBC
Any other bladder cancer patients experience that burning urination after BCG?
Mine is like fire for 2-3 days.
#bladdercancer #bcgtreatment #jonhamm
Mine is like fire for 2-3 days.
#bladdercancer #bcgtreatment #jonhamm
December 23, 2025 at 7:19 PM
Any other bladder cancer patients experience that burning urination after BCG?
Mine is like fire for 2-3 days.
#bladdercancer #bcgtreatment #jonhamm
Mine is like fire for 2-3 days.
#bladdercancer #bcgtreatment #jonhamm
#duet with @Dr. Amit Garg 🩸 This is immunotherapy advice I have seen a few times. 18 BCG treatments down for me so far. 17 have been morning appointments. Still NED 🙏Very interesting. Something a bladder cancer patients should consider and discuss with their doctor. #bladdercancer #bcgtreatment
December 22, 2025 at 3:14 PM
#duet with @Dr. Amit Garg 🩸 This is immunotherapy advice I have seen a few times. 18 BCG treatments down for me so far. 17 have been morning appointments. Still NED 🙏Very interesting. Something a bladder cancer patients should consider and discuss with their doctor. #bladdercancer #bcgtreatment
Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer
buff.ly/WyNXj23
#BladderCancer, #TumorStroma, #TME, #CancerResearch
buff.ly/WyNXj23
#BladderCancer, #TumorStroma, #TME, #CancerResearch
December 22, 2025 at 1:50 PM
Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer
buff.ly/WyNXj23
#BladderCancer, #TumorStroma, #TME, #CancerResearch
buff.ly/WyNXj23
#BladderCancer, #TumorStroma, #TME, #CancerResearch
Sarasota Memorial Hospital has joined a major global trial testing a novel bladder cancer treatment that could help patients live longer with fewer side effects. Read more: www.yourobserver.com/news/2025/de... #BladderCancer #ClinicalTrials #CancerTreatment #Oncology #Hope #TCSC
SMH participates in global bladder cancer treatment clinical trial | Your Observer
Kolschowsky Research and Education Institute at Sarasota Memorial Hospital is seeking candidates diagnosed with non-muscle-invasive bladder cancer for global clinical trial.
www.yourobserver.com
December 21, 2025 at 11:58 AM
Sarasota Memorial Hospital has joined a major global trial testing a novel bladder cancer treatment that could help patients live longer with fewer side effects. Read more: www.yourobserver.com/news/2025/de... #BladderCancer #ClinicalTrials #CancerTreatment #Oncology #Hope #TCSC